OPEN END TURBO SHORT - BECTON DICKINSON AND CO. Stock

Certificat

DE000MB965C4

Market Closed - Bid/Ask 12:09:26 2024-06-26 EDT After market 14:48:33
6.21 EUR +3.33% Intraday chart for OPEN END TURBO SHORT - BECTON DICKINSON AND CO. 6.275 +1.05%
Current month-4.75%
1 month-7.82%
Date Price Change
24-06-26 6.21 +3.33%
24-06-25 6.01 +2.04%
24-06-24 5.89 +4.06%
24-06-21 5.66 0.00%
24-06-20 5.66 -6.91%

Delayed Quote Börse Stuttgart

Last update June 26, 2024 at 12:09 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN MB965C
ISINDE000MB965C4
Date issued 2023-07-26
Strike 298.5 $
Maturity Unlimited
Parity 10 : 1
Emission price 1.9
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 7.08
Lowest since issue 1.39
Spread 0.03
Spread %0.48%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
233.9 USD
Average target price
279.2 USD
Spread / Average Target
+19.38%
Consensus